| Display title | Chemistry:L-163,491 |
| Default sort key | L-163,491 |
| Page length (in bytes) | 3,549 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 2223207 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>MainAI |
| Date of page creation | 11:14, 6 March 2023 |
| Latest editor | imported>MainAI |
| Date of latest edit | 11:14, 6 March 2023 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | L-163,491 is an experimental drug which acts as a partial agonist of angiotensin II receptor type 1, and with lower affinity as an agonist of angiotensin II receptor type 2, mimicking the action of angiotensin II. Its practical applications to date have been limited to scientific research into the function... |
